As of April 2, 2026, NeuroMetrix Inc (NURO) reports a Current Ratio of 14.83.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of NeuroMetrix Inc's Current Ratio
Over recent years, NeuroMetrix Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 14.83 |
| 2023-12-31 | 16.81 |
| 2022-12-31 | 21.72 |
| 2021-12-31 | 17.66 |
| 2020-12-31 | 3.10 |
This slight downward trend highlights how NeuroMetrix Inc manages its short-term assets and liabilities over time.
Comparing NeuroMetrix Inc's Current Ratio to Peers
To better understand NeuroMetrix Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| NeuroMetrix Inc (NURO) | 14.83 |
| Stock Trend Capital Inc (PUMP.CN) | 19.94 |
| Viveve Medical Inc (VIVE) | 4.91 |
| Intuitive Surgical Inc (ISRG) | 4.87 |
| Scientific Industries Inc (SCND) | 4.74 |
| Edwards Lifesciences Corp (EW) | 3.72 |
Compared to its competitors, NeuroMetrix Inc's Current Ratio is among the highest compared to peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.